Topic Archives: Junior Mining Monthly

The talk of trade war with China is bringing the idea of Chinese mineral dominance back to the pages of investment teaser ads… we’ve seen several in the last week or two that focus on rare earths, where China remains dominant and might have some extra negotiating leverage in trade disputes, and this latest pitch […]

Today we look into the teased “Gold-X” from Gerardo Del Real, who writes the Junior Mining Monthly newsletter and calls himself a “Texas gold expert” … his ad promises an easier way to get huge returns on little gold stocks while taking a lot less risk. “Gold-X” seems an odd name for a “secret” investing […]

Stopped publishing abruptly in October 2020, when Del Real and Nick Hodge left Outsider Club/Angel Publishing to form a new publisher called Resource Stock Digest. A similar newsletter is being launched by Del Real under the new publisher, titled Junior Resource Monthly. Natural resources investment advisory, with monthly issues recommending junior mining stocks. Formerly titled […]

Comments

  • SoGiAm

    #Biotech Best turnaround M&A $ARQL 20X $MRK BO in 2yr $ARRY $2s Multiple setbacks ➡️ 20X $PFE BO in 3yr $ECYT...

  • Avatar

    AGN has been a perpetual R&D disappointer. Botox SB ok, but the pipeline is mediocre at best, and stock is not that chea...

  • Avatar

    Travis ---you're right on-----The five he talks about are: ABBV, PFE, JNJ, MRK amd UNH...

  • Avatar

    ABBV has been in a down trend channel since 26 jan 2018...

  • Avatar

    Although this investment letter has done well in the past, since late 2018 it has been the fastest way to lose money I'v...

  • Avatar

    ABBV has been a very good stock over the past 1.5 years. One subscription service said to sell when it fell a month or t...

  • Jay Ram

    Must be Abbvie (ABBV). They want to tender $7.5B worth of their own stock. Sure makes me curious about buying, although ...

  • SoGiAm

    AbbVie's stock climbs after positive late-stage trial results of psoriasis treatment Today 8:12 AM ET (MarketWatch) Sh...

  • SoGiAm

    $ENTA $ABBV MAVIRET™ (glecaprevir/pibrentasvir) Is Now Available in Japan for the Treatment of Chronic Hepatitis C Acr...

  • Avatar

    $AUPH. He made millions in Pharmacyclics (PCYC) which was sold to Abbvie (ABBV). Two or three years ago my first (very...

  • Avatar

    $ABBV $GILD $AMGN - An interesting article from IBD evaluating comparatively three biotech giants "AbbVie Stronger B...

  • Avatar

    $RGLS (long) http://tinyurl.com/z6qeum9 AbbVie ($ABBV) is touting impressive cure rates for its new daily hep C combo...

  • Avatar

    GILD's HEP C scripts latest data. Gilead Sciences: Does Anyone Care About Hep-C Anymore? By Ben Leviso...

  • Avatar

    Got this teaser for a prescription buy to Money Map Press.It was easy to figure out the company.It is Orasure Technologi...

  • Avatar

    I started watching Mike Ward's pitch this afternoon and decided I could dope this out on my own. I spent 6 hours learnin...

  • Avatar

    The following is an excerpt from a piece on GILD: "A group of developers are racing ahead in the clinic with new hep C ...

  • karmaswimswami

    Readers here who might be more comfortable with a blue-chip rather than a speculative pick might really want to take a l...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info